2-Fluoro-4-(trifluoromethyl)phenylacetonitrile, 98.0%, 1g

Ethyl 2-(dibenzylamino)acetate, 95.0%, 100g

ETHYL 6-FLUORO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-2-CARBOXYLATE, 95.0%, 250mg

3,5-Dichlorobenzonitrile, 99.0%, 25g

1H-Pyrrolo[3,2-c]pyridine, 96.00%, 100g

2-Amino-2-(3-(trifluoromethyl)phenyl)acetic acid hydrochloride, 95.0%, 100mg

Monoclonal de ratón con etiqueta anti-DDDDK, AP1501, 25 µg

(S)-3-((tert-Butoxycarbonyl)amino)-4-hydroxybutanoic acid, 95.0%, 1g

1,2,3-Tris(trifluoromethyl)benzene, 97.0%, 1g

Methyl 4-bromo-1-ethyl-3-methyl-1H-pyrazole-5-carboxylate, 95.0%, 100mg

4-Butylmorpholine, 95.0%, 100g

Lovastatin, >95%, 100g

6-Iodoquinazoline, 95.0%, 5g